We are updating this page as needed to provide resources related to the COVID-19 vaccine.

Update May 6, 2021
Another way to determine where vaccines are available in your area: text “getvax” (438829) to receive a text reply with a list of vaccine site locations.

Update May 4, 2021

Walk in availability for ages 18 and older at RRHD Clinic at Germanna Community College for the Moderna vaccine
May 5, 8:30 – 11:30 am
May 13, noon – 7:30 pm
May 14, 8:30 am – noon
Those seeking a vaccine should simply drive in during any of the clinic times listed above and let the volunteer know they are there to get a Covid-19 shot. Information or schedule an appointment: 540-308-6072.

Update April 27, 2021

WALK IN AVAILABILITY AT RRHD Clinic at Germanna Community College

WEDNESDAY, APRIL 29, 9-11:30 am for walk-ins. Drive in and let the volunteer know you are there for a Covid shot.

If you’d prefer to make an appointment:

https://vaccineappointments.virginia.gov/client/registration?clinic_id=3909 for Wednesday, April 28, 2021: 8:30 – 11:45 a.m.

https://vaccineappointments.virginia.gov/client/registration?clinic_id=3910 for Wednesday, April 28, 2021: 1 – 3 p.m.

If you need assistance by phone, call 540-308-6072.

Important information to consider before getting a COVID-19 vaccination at an RRHD clinic:

  • If an individual has had an allergic reaction to any injectable medication or injectable vaccine in the past requiring either epinephrine or an emergency room visit, that individual will need to bring a hard copy of the Physician, Physician’s Assistant or Nurse Practitioner’s note advising it is OK to receive the COVID 19 vaccine.
  • Unless you require assistance, you may not have anyone accompany you into the building for your vaccination, and you will be asked to wait 15 minutes after receiving your dose of the vaccine. Please plan accordingly.
  • Any individual who has recently received any vaccine must wait 14 days before receiving the COVID 19 vaccine.
  • Any individual under isolation or quarantine must wait until after the isolation or quarantine period to receive the vaccine.

Please remember to continue masking and social distancing outside your household.  We will reach a point later this year when enough people are vaccinated where these actions are no longer necessary, but we’re not there yet.  We ask all residents to continue to watch your 4Ws:  Wear your mask, Watch your distance, Wash your hands, and Wait to return to work or school if you’re sick.

For more information on COVID-19 in Virginia, visit www.vdh.virginia.gov/covid-19-vaccine/.

Update April 15, 2021
From the Rappahannock-Rapid Health District Facebook page:
RRHD has moved to Phase 2 for COVID-19 vaccinations. All residents age 16 and older (Pfizer) and 18 and older (Moderna, J&J) are now eligible to receive COVID-19 vaccine.
If you are looking for a COVID-19 vaccine, we now recommend you use vaccinefinder.org. RRHD will no longer use the vaccinate.virginia.gov pre-registration list. We will make one more attempt to reach residents that completed the pre-registration but have not responded to appointment offers.
If you have signed up on the pre-registration list and have not received an appointment, please call 540-316-6302 or email askrrhd@vdh.virginia.gov. A staff member will assist you with making an appointment.

(Note: vaccinefinder.org referenced above is updated daily and identifies clinics, pharmacies and other locations that offer Covid-19 vaccines in the United States; you will need to share your zip code to determine local availability.)

Update April 13, 2021

From the Rappahannock-Rapidan Health District Facebook page:

Statement from Virginia State Vaccination Coordinator Dr. Danny Avula
On Pause in Administration of Johnson and Johnson Vaccine
(Richmond, Va.) — We are closely monitoring the actions by the federal government to pause all Johnson & Johnson vaccinations while it investigates an extremely rare possible side effect. In Virginia, we will cease all Johnson &Johnson vaccines until this investigation is complete. If you have an upcoming appointment for the Johnson & Johnson vaccine, you will be contacted to reschedule that appointment.

Update April 12, 2021
From the Rappahannock-Rapidan Health District Facebook page:
This week’s (April 12) projected pharmacy COVID-19 vaccine opportunities. The amount of vaccine available is subject to change, so please visit the individual pharmacy websites for additional information.

Update March 29, 2021
From the Rappahannock-Rapidan Health District Facebook page:
RRHD recently sent out a COVID-19 vaccination invitation via email to some residents on the pre-registration list. This email is automatically generated through the scheduling software, PrepMod, and we know that many of you were concerned that it was a scam.
If you received an email with the title “COVID-19 Registration Invitation” from Vaccination Clinics <no-reply@multistatep4p.com> it is a real invitation to the RRHD centrally located clinic.
You may also want to check your spam folders for this email.

Update March 15, 2021

Updated vaccine FAQs from Novant Health UVA Health System. Please click on the links below.

Update March 3, 2021

The following information was provided locally by Novant Health UVA Health System Culpeper Medical Center

FAQs on Johnson & Johnson COVID-19 Vaccine 
Note: Information is subject to change. This document is current as of March 3, 2021.
Johnson & Johnson and Janssen co-developed a new COVID-19 vaccine. While Johnson & Johnson is the name most know this new vaccine by, it was actually co-developed by Johnson & Johnson and Janssen. Therefore, patients who receive this vaccine will see Janssen in their medical record, not Johnson & Johnson. The one-dose vaccine is safe and effective in preventing hospitalization and death due to COVID-19 with no serious safety concerns.

Is the vaccine safe?
Yes, similar to the Moderna vaccine, the Johnson & Johnson vaccine is safe for people age 18 and older (the Pfizer-BioNTech COVID-19 vaccine is authorized for use in people aged 16 years or older). The U.S. Food and Drug Administration (FDA) found it to be safe and effective, and they authorized it for emergency use on Feb. 27, 2021. According to Johnson & Johnson, it offers complete protection against hospitalization and death as a result of the virus.
Is the one-dose vaccine as effective as the Moderna or Pfizer? 
The one-dose vaccine is effective and can protect people from COVID-19. All three vaccines are 100 percent effective in preventing COVID-19-related hospitalization and death once fully vaccinated. All three vaccines are also extremely effective in preventing symptomatic or severe cases of the virus.

Protection from the vaccine begins about two weeks after receiving the shot. Like other vaccines, it takes time for the body to develop protection.

Why do patients receive one shot instead of two?
The Johnson & Johnson vaccine works differently in the body than the two-dose vaccines, which is why people receive just one dose. This method has been used for many years to develop successful vaccines for use in people.

The one-dose vaccine is a viral vectored vaccine, which uses a harmless type of virus to help the body make a specific protein to trigger an immune response to COVID-19. The two-dose vaccines use messenger RNA, or mRNA, that teach the body how to make a protein to trigger an immune response to COVID-19.

The vaccine is also easier to store than other vaccines. It can be stored at normal refrigerator temperatures for up to three months, meaning we can more easily get it into the community to vaccinate more people against COVID-19.
What are the side effects of the Johnson & Johnson vaccine?
Similar to the two-dose vaccines, people may experience cold-like symptoms, such as headache, body aches, arm pain and tiredness. Fewer than 10 percent of participants experienced a fever and no one in the Johnson & Johnson one-dose study reported a severe allergic reaction.
What are the benefits of one dose?
A single-dose vaccine may be desirable for people who want to complete their immunization schedule quickly, do not want to return for a second dose or have difficulty returning for a second dose. A single-dose vaccine is beneficial for areas where it is difficult to schedule appointments online or store the vaccines.
Does the vaccine protect against new strains or variants of the virus?
Johnson & Johnson is continuing to study effectiveness against new variants. So far, the one-dose vaccine has been more than 80 percent effective at preventing severe disease across United States, Brazil and South Africa populations.

We know the vaccines available now are safe and effective. The most important thing right now is to get as many people as possible vaccinated using the vaccines available so we can better protect people in our communities.
Who was included in the clinical trials for the Johnson & Johnson vaccine?
The clinical trial pool for Johnson & Johnson was diverse. In the United States, 74 percent were White/Caucasian; 15 percent were Hispanic/Latinx; 13 percent were Black/African American; 6 percent were Asian and 1 percent were Native American.

Forty-one percent of participants in the study had health conditions associated with an increased risk for developing severe COVID-19 (overall 41 percent), obesity (28.5 percent), type 2 diabetes (7.3 percent), hypertension (10.3 percent), HIV (2.8 percent). Other immunocompromised participants were also in the study.
Can people choose which vaccine they want to get?
Given the limited amount of vaccine supply available, people are not able to choose the type of vaccine they will receive. All vaccines currently available are safe and protect people against COVID-19. Regardless of which vaccine you receive, you will be better protected than if you did not receive a vaccine. The most important thing right now is to get as many people vaccinated using the vaccines available. Herd immunity will better protect people in our communities.

Sources: Johnson & Johnson
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial | Johnson & Johnson (jnj.com)

Update 2/12/21: Virginia launches statewide pre-registration system

(Source: Rappahannnock-Rapidan Health District/RRHD)
Starting at 8 a.m. on Tuesday, February 16th, 2021, the Commonwealth of Virginia will launch a statewide vaccine pre-registration system at vaccinate.virginia.gov. This will be a centralized website for all state residents to pre-register for vaccines.
According to RRHD, here is what this means for you:
– If you’ve already filled out a RRHD survey form you will automatically be transferred into the new system. You will maintain your place in the queue, and won’t be giving up your place in line. Starting Tuesday morning, you will also be able to search this system to ensure your name is included.
– If you haven’t filled out the RRHD survey form: disregard the form, and visit vaccinate.virginia.gov to pre-register.
– If you are a business: this change will not affect businesses that have completed the Phase 1A/1B Essential Worker Survey. RRHD will continue to manage vaccines for essential personnel.
– The RRHD registration survey will no longer be active starting Friday, February 12, at 5 p.m. to allow for the transition to the new system. If you haven’t yet registered, please wait until February 16th at 8 a.m. and use the new system at vaccinate.virginia.gov.
In response to some FAQs:
– If you have questions, contact the new Virginia call center hotline at 877-275-8343. It is open from 8 a.m. to 8 p.m. daily, with staff available to help those who don’t have computers or have difficulty using them. Language translation will be available.
– If you registered two people but used one email address for both (e.g., parents, couples, etc.), that is OK. The system will use full name and date of birth and other unique characteristics to identify unique individuals.
– The system is unable to provide your “number” or place in the queue. There are not enough doses available for everyone who is eligible to receive a vaccine. The latest knowledge as of February 12 is that Virginia is not likely to meet the demand for Phase 1b until March or April. It may be weeks or longer before vaccination appointments become available for those who have pre-registered. Please remember that RRHD is working through the list as quickly as they can with the number of vaccine doses available.

Culpeper County Vaccine Help Line begins Monday, February 8

Operated by the county’s Office of Emergency Services 10:00 am – 2:00 pm weekdays. A service will be available to request a return call. EMS staff at the call center will answer questions and help those without internet to complete the Health District’s online survey to register to obtain the vaccine. The Health Department continues to register citizens according to their priority group at https://www.vdh.virginia.gov/rappahannock-rapidan/ – scroll down to find the appropriate survey.
Help line: 540-727-9719
Email help line: covid19@culpepercounty.gov

Answers to frequently asked questions: short video from Novant Health UVA Health: https://vimeo.com/503049367  (English) and https://vimeo.com/507686936 (Spanish)

Suggestion from the Virginia Department of Health: Remember to save your vaccination card in a safe place. The vaccination card tells you which COVID-19 vaccine you received, the date you received it, and where you received it.